Mesa Laboratories (MLAB) Debt to Equity (2011 - 2025)

Mesa Laboratories has disclosed Debt to Equity across 15 years of filings, most recently posting $0.34 for Q4 2025.

• Debt to Equity for Q4 2025 came in at $0.34, down 26.19% year-over-year; the trailing twelve-month figure through Dec 2025 was $0.34 (down 26.19% YoY), and the FY2025 annual result was $0.09, changed N/A from the prior year.
• Debt to Equity came in at $0.34 for Q4 2025 at Mesa Laboratories, down from $0.39 in the prior quarter.
• In the past five years, Debt to Equity ranged from a high of $0.82 in Q3 2024 to a low of $0.0 in Q1 2021.
• The 5-year median for Debt to Equity is $0.14 (2022), against an average of $0.23.
• Across the five-year window, Debt to Equity soared 21409.0% in 2022 and sank 89.56% in 2023, its largest moves.
• Mesa Laboratories' Debt to Equity stood at $0.15 in 2021, then plunged by 67.59% to $0.05 in 2022, then soared by 213.56% to $0.15 in 2023, then jumped by 195.85% to $0.46 in 2024, then declined by 26.19% to $0.34 in 2025.
• The last three Debt to Equity figures came in at $0.34 (Q4 2025), $0.39 (Q3 2025), and $0.4 (Q2 2025), per Business Quant data.